ustransplant.org

Transplant Statistics: Annual Report : Reference Tables

Annual Report | Chapters | Data By Category | Data By Organ | Technical Notes | Glossary | Appendices

Table 14.8
De Novo Posttransplant Solid Malignancy, 1992 to 2001
Liver Recipients

Malignancies by Type Year of Transplant
1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
Total # of Post-Tx Malignancies 65 86 62 102 83 81 84 68 36 13
Squamous/Basal Cell Carcinoma 29 37 22 46 38 32 30 21 15 5
Melanoma 1 2 1 1 2 1 1 2 1 -
Kaposi Sarcoma - - - - - - - 4 2 1
Central Nervous System 1 - - - 4 - 1 - - -
Genito-Urinary (1) 3 7 5 5 4 7 9 2 3 1
Gastro-Intestinal (2) 9 12 15 12 17 14 19 11 4 5
Primary Hepatic Tumor 1 1 1 1 4 4 5 6 2 -
Metastatic Hepatic Tumor 1 2 - 1 1 2 2 1 2 1
Larynx/Bronchi/Lung 4 12 8 16 9 6 10 6 5 -
Breast/Thyroid/Adrenal 4 6 6 9 2 6 1 6 - -
Leukemia - - 1 3 1 1 1 - - -
Sarcoma (3) - 1 - - - - - - - -
Other 11 6 1 6 1 5 4 5 1 -
Unknown 1 - 2 2 - 3 1 4 1 -
Squamous/Basal Cell Carcinoma 44.6% 43.0% 35.5% 45.1% 45.8% 39.5% 35.7% 30.9% 41.7% 38.5%
Melanoma 1.5% 2.3% 1.6% 1.0% 2.4% 1.2% 1.2% 2.9% 2.8% -
Kaposi Sarcoma - - - - - - - 5.9% 5.6% 7.7%
Central Nervous System 1.5% - - - 4.8% - 1.2% - - -
Genito-Urinary (1) 4.6% 8.1% 8.1% 4.9% 4.8% 8.6% 10.7% 2.9% 8.3% 7.7%
Gastro-Intestinal (2) 13.8% 14.0% 24.2% 11.8% 20.5% 17.3% 22.6% 16.2% 11.1% 38.5%
Primary Hepatic Tumor 1.5% 1.2% 1.6% 1.0% 4.8% 4.9% 6.0% 8.8% 5.6% -
Metastatic Hepatic Tumor 1.5% 2.3% - 1.0% 1.2% 2.5% 2.4% 1.5% 5.6% 7.7%
Larynx/Bronchi/Lung 6.2% 14.0% 12.9% 15.7% 10.8% 7.4% 11.9% 8.8% 13.9% -
Breast/Thyroid/Adrenal 6.2% 7.0% 9.7% 8.8% 2.4% 7.4% 1.2% 8.8% - -
Leukemia - - 1.6% 2.9% 1.2% 1.2% 1.2% - - -
Sarcoma (3) - 1.2% - - - - - - - -
Other 16.9% 7.0% 1.6% 5.9% 1.2% 6.2% 4.8% 7.4% 2.8% -
Unknown 1.5% - 3.2% 2.0% - 3.7% 1.2% 5.9% 2.8% -
Total # of Patients 45 71 52 72 67 69 66 57 30 12

Source: OPTN/SRTR Data as of August 1, 2002.
(-) = None in category.
(1) Genito-Urinary: kidney, bladder, uterine cervix, uterine body, ovarian, vulva, testicular, prostate.
(2) Gastro-Intestinal: tongue, throat, esophagus, stomach, small intestine, colo-rectal, liver and biliary
tract, pancreas.
(3) Sarcoma: fibrosarcoma, osteosarcoma, etc.
Patients may have more than one posttransplant malignancy reported due to multiple follow-up forms.
Recipient malignancy statistics are based on voluntary reporting to the OPTN.

Annual Report | Chapters | Data By Category | Data By Organ | Technical Notes | Glossary | Appendices

Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline

Home | Who We Are | What We Do | About Transplants | Transplant Statistics | Research Resources | Contact Us | Site Map

SRTR Site designed and maintained by Diamond Bullet Design & URREA.